Fresh Recalls

Hikma Pharmaceuticals USA recalls

2 recent recalls on record for Hikma Pharmaceuticals USA in connected official government data as of October 22, 2026 at 6:00 PM UTC.

Models with recalls

Alendronate Sodium Oral Solution (1)Ramipril Capsules USP (1)

All Hikma Pharmaceuticals USA recalls

FDA Class II · Drug · September 2, 2026

Ramipril Capsules USP recall — Hikma Pharmaceuticals USA INC.

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Official ID D-0831-2026 · Official record ↗

FDA Class II · Drug · May 6, 2026

Alendronate Sodium Oral Solution recall — Hikma Pharmaceuticals USA INC

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Official ID D-0526-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.